SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - TRACON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 47 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$205,000
-23.5%
31,616
-3.0%
0.00%
-20.0%
Q1 2021$268,000
-30.2%
32,593
-0.7%
0.01%
-28.6%
Q4 2020$384,000
+188.7%
32,816
+27.6%
0.01%
+75.0%
Q3 2020$133,000–25,716–0.00%–
 Download
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$9,004,9202.70%
Ikarian Capital, LLC 2,765,530$5,226,8511.19%
JOHNSON & JOHNSON 84,003$158,7660.05%
X-Square Capital, LLC 17,743$340.02%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$489,2150.01%
LINDEN ADVISORS LP 454,916$859,7910.01%
HoyleCohen, LLC 13,000$24,5700.00%
MGO ONE SEVEN LLC 11,780$22,2640.00%
Bank of New York Mellon Corp 66,606$125,8850.00%
Citadel Advisors 24,700$46,6830.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders